Ramino Bio
Ness Ziona
About Ramino Bio
Ramino Bio is a private biotech company that develops an oral drug to treat metabolic diseases. Ramino has received funding totaling about $3.3 million since its beginning from the FutuRx biotech incubator, which is supported by the Israeli Innovation Authority, Takeda, J&J, OrbiMed, and RMPG. By speeding up their disintegration, our exclusive technology lowers the extra BCAA that is floating around.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Funding stage: Seed
- Last round: Seed (Sep 2018)
- Website: ramino-bio.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Life Science
Canonical: https://fsome.com/organization/ramino-bio-3085573 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.